ARCHIVES

ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury

This article is from The Cancer Letter archive.

Vol. 28 No. 24 | June 14, 2002

Download PDF Visit The Full Archive

Related Articles

NCAB Votes No To Funding Diet FIT, Citing NCI Resources

December 8, 1989

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014

Trials Approved by NCI CTEP For the Month of December

December 30, 2011

NCAB Subcommittee Suggests Comp Centers Must Have Core Grants

September 22, 1978

Clinical Trial System Inefficient, UPCI Director Tells Senate

June 7, 2002

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

October 7, 1994